|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | +2.04% |
|
+5.26% | +45.99% |
| Market Cap | 690M 602M 557M 522M 977M 65.1B 985M 6.61B 2.56B 32.05B 2.59B 2.54B 111B | P/E 2026 * |
-2.85x | P/E 2027 * | -2.67x |
|---|---|---|---|---|---|
| Enterprise Value | 505M 440M 407M 381M 714M 47.59B 720M 4.83B 1.87B 23.43B 1.89B 1.85B 81.38B | EV / Sales 2026 * |
84,104x | EV / Sales 2027 * | 45.4x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | +2.04% | ||
| 1 week | +5.26% | ||
| Current month | -7.83% | ||
| 1 month | +5.82% | ||
| 3 months | -9.91% | ||
| 6 months | +40.85% | ||
| Current year | +45.99% |
| 1 week | 1.9 |  | 2.1 |
| 1 month | 1.75 | | 2.32 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 6.05 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Chang
CEO | Chief Executive Officer | 66 | 31/05/2018 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 15/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 27/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 31/10/2017 |
David Chang
BRD | Director/Board Member | 66 | 31/05/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 31/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-20 | Sell | Controller/Auditor | 9,586 | 0.0039% | ||
| 03-30 | Sell | Chief Technology Officer | 2,867 | 0.0013% | ||
| 03-15 | Sell | Founder | 47,763 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +5.26% | +55.04% | -58.76% | 690M | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| Average | +1.48% | +2.65% | +38.52% | +90.57% | 21.49B | |
| Weighted average by Cap. | +1.63% | +1.49% | +40.96% | +99.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6K 5.23K 4.84K 4.53K 8.49K 566K 8.56K 57.44K 22.26K 279K 22.52K 22.04K 968K | 12.97M 11.31M 10.46M 9.8M 18.36M 1.22B 18.5M 124M 48.13M 602M 48.69M 47.65M 2.09B |
| Net income | -197M -171M -159M -149M -278M -18.54B -280M -1.88B -729M -9.13B -738M -722M -31.7B | -227M -198M -183M -172M -321M -21.42B -324M -2.17B -843M -10.55B -853M -834M -36.63B |
| Net Debt | -186M -162M -150M -140M -263M -17.51B -265M -1.78B -689M -8.62B -697M -682M -29.95B | -101M -87.89M -81.28M -76.18M -143M -9.51B -144M -965M -374M -4.68B -378M -370M -16.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 2.000 $ | +2.04% | 23,548,239 |
| 17/06/26 | 1.960 $ | +3.16% | 6,362,245 |
| 16/06/26 | 1.900 $ | -2.06% | 5,045,927 |
| 15/06/26 | 1.940 $ | +2.11% | 5,800,150 |
| 12/06/26 | 1.900 $ | +1.06% | 8,642,431 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
